BRCA1 and hypoparathyroidism-retardation-dysmorphism syndrome: Around 15% of TNBC are characterized by HRD linked to germline or somatic BRCA1/2 mutations7, and 40% are found to harbor HRD without gBRCA1/2 mutation2, and could have a specific sensitivity to DNA-damaging agents.